INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 11,439 Value ($000) $212 Avg Close — Range —
Q2 2023
Shares 48,477 Value ($000) $536 Avg Close — Range —
Q1 2023
Shares 12,288 Value ($000) $165 Avg Close — Range —
Q4 2022
Shares 11,353 Value ($000) $140 Avg Close — Range —
Q3 2022
Shares 28,420 Value ($000) $396 Avg Close — Range —
Q2 2022
Shares 14,844 Value ($000) $205 Avg Close — Range —
Q1 2021
Shares 12,432 Value ($000) $287 Avg Close — Range —
Q2 2019
Shares 2,588 Value ($000) $206 Avg Close — Range —
Q3 2016
Shares 2,378 Value ($000) $391 Avg Close — Range —
Q1 2015
Shares 1,442 Value ($000) $407 Avg Close — Range —
Q3 2014
Shares 2,529 Value ($000) $599 Avg Close — Range —